UBS Maintains a 'Buy' on Cepheid (CPHD); Q2 Review
Tweet Send to a Friend
UBS maintains a 'Buy' on Cepheid (NASDAQ: CPHD) price target of $43.00 (from $45.00).
Analyst, Daniel Arias, said, "Sales ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Daniel Arias, said, "Sales ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE